Related references
Note: Only part of the references are listed.Small-Molecule Inhibition of Human Immunodeficiency Virus Type 1 Replication by Targeting the Interaction between Vif and ElonginC
Tao Zuo et al.
JOURNAL OF VIROLOGY (2012)
SAR and Lead Optimization of an HIV-1 Vif-APOBEC3G Axis Inhibitor
Idrees Mohammed et al.
ACS MEDICINAL CHEMISTRY LETTERS (2012)
Recent progress in synthesis and bioactivity studies of indolizines
Girija S. Singh et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Novel approaches to inhibiting HIV-1 replication
Catherine S. Adamson et al.
ANTIVIRAL RESEARCH (2010)
Baculiferins A-O, O-sulfated pyrrole alkaloids with anti-HIV-1 activity, from the Chinese marine sponge Iotrochota baculifera
Guotao Fan et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Small Molecular Compounds Inhibit HIV-1 Replication through Specifically Stabilizing APOBEC3G
Shan Cen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Molecular Insight into the Conformational Dynamics of the Elongin BC Complex and Its Interaction with HIV-1 Vif
Sean R. Marcsisin et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Novel targets for HIV therapy
Warner C. Greene et al.
ANTIVIRAL RESEARCH (2008)
Structural insight into the human immunodeficiency virus Vif SOCS box and its role in human E3 ubiquitin ligase assembly
Bradford J. Stanley et al.
JOURNAL OF VIROLOGY (2008)
Cytidine Deaminases as a Weapon Against Retroviruses and a New Target for Antiviral Therapy
Akifumi Takaori-Kondo et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2008)
Small-molecule inhibition of HIV-1 Vif
Robin Nathans et al.
NATURE BIOTECHNOLOGY (2008)
Three-dimensional structure of HIV-1VIF constructed by comparative modeling and the function characterization analyzed by molecular dynamics simulation
Wei Lv et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2007)
Prevalence of antiretroviral drug resistance and resistance-associated mutations in antiretroviral therapy-naive HIV-infected individuals from 40 United States cities
Lisa Ross et al.
HIV CLINICAL TRIALS (2007)
A zinc-binding region in vif binds cul5 and determines cullin selection
Andrew Mehle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Assembly of HIV-1 Vif-Cul5 E3 ubiquitin ligase through a novel zinc-binding domain-stabilized hydrophobic interface in Vif
Zuoxiang Xiao et al.
VIROLOGY (2006)
Oxidant promoted 1,3-dipolar cycloaddition of pyridinium ylides to chalcones for preparation of 1-benzoyl-2-arylindolizines
BX Wang et al.
CHINESE JOURNAL OF CHEMISTRY (2006)
VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases
T Kamura et al.
GENES & DEVELOPMENT (2004)
The prevalence of antiretroviral drug resistance in the United States
DD Richman et al.
AIDS (2004)
Expression of HIV-1 accessory protein Vif is controlled uniquely to be low and optimal by proteasome degradation
M Fujita et al.
MICROBES AND INFECTION (2004)
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
B Mangeat et al.
NATURE (2003)
DNA determination mediates innate immunity to retroviral infection
RS Harris et al.
CELL (2003)
Hypermutation of HIV-1 DNA in the absence of the Vif protein
D Lecossier et al.
SCIENCE (2003)
Share Paper
